Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination

SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination

Zouhair Souissi

Bibliographie

22 mars 2021

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies – Cell

The post SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination appeared first on Links Medicus.

Lu 671 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7 [Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche